Since Genmab’s founding in 1999, our work has been anchored in our core purpose which summarizes what we strive for – our unstoppable team will improve the lives of patients through innovative and differentiated antibody therapeutics.
With our core purpose and core values of innovation, determination, integrity and teamwork, being sustainable and socially responsible is fundamental to the way we work at Genmab.
“Genmab is a purpose-driven company. We are motivated by the difference we can make in the lives of people with cancer and other serious diseases and on society as a whole. Genmab is committed to being a sustainable and socially responsible company. Guided by our vision, our corporate social responsibility strategy is anchored in our purpose, aligned with our core values, and integrated into our business operations.”
Jan G. J. van de Winkel, Ph.D. President & CEO
Our commitment to CSR is anchored in our company’s core purpose that summarize what we strive for – our unstoppable team will improve the lives of patients through innovative and differentiated antibody therapeutics. It supports our vision that by 2030 our knock-your-socks-off antibody medicines (KYSO antibody medicines®) are fundamentally transforming the lives of people with cancer and other serious diseases. Our vision inspires and motivates us.
We are committed to ensure our actions benefit our stakeholders – patients, caregivers, healthcare professionals, employees, our partners, shareholders – and society as a whole. Being socially responsible is fundamental to the way we work at Genmab.
Genmab’s comprehensive approach to corporate social responsibility (CSR) is grounded in our commitment to sustainability, driven by our purpose and vision, and guided by our core values. We have implemented CSR-related policies, procedures and programs to ensure that the value we provide to our stakeholders is long-lasting. Read more about how we are integrating CSR into our operations.
Click the icons below to learn more.
Genmab has identified an initial set of performance indicators that will enable us to better manage and measure our impact going forward, and fulfill our commitment to sustainability. We have committed to UN Sustainable Development Goals and adopted the Sustainability Accounting Standards Board (SASB) framework and will follow its guidelines to disclose critical measurements on environment, society and governance (ESG) matters of relevance to our business operations.
We continue to move our sustainability efforts forward, look for opportunities to further integrate ESG into our strategic planning and risk management processes, monitor ESG issues of relevance to our business operations and establish clear goals to measure our performance.
The Board of Directors and senior leadership are committed to Genmab’s business-driven CSR strategy, which focuses on four main areas – click each pillar to learn more.
Our CSR Committee, co-chaired by our CEO and SVP Global Communications and Corporate Affairs, ensures that Genmab carries out CSR activities effectively and communicates them clearly and openly. The Nominating and Corporate Governance Committee oversees all aspects of Genmab’s CSR efforts and provides recommendations to the Board of Directors regarding CSR and ESG issues. The Audit and Finance Committee has oversight for ESG reporting requirements.
Genmab is making strides towards its goals of sustainability and social responsibility through support of nonprofit and non-governmental organizations that are dedicated to making a difference to people, their communities and the environment. Genmab is proud to support these efforts through its charitable donation program.
We seek strategic engagement with our partners, and support organizations and programs that offer opportunities to engage Genmab employees as well as those that align with our Diversity, Equity & Inclusion (DE&I) efforts.
Learn more about our Guidelines that we use to evaluate charitable requests.
If interested in submitting requests for Medical Education Grants, Scientific Sponsorships and Patient Advocacy Sponsorships, please click here.
Currently, we are accepting proposals by invitation only.
If you have questions, kindly contact Genmab at [email protected].
Comprised of 17 goals, the United Nations Sustainable Development Goals (UNSDGs) are an urgent call for action by countries aiming to end poverty and other deprivations to improve health and education, reduce inequality, spur economic growth and tackle climate change.
We’ve adopted the Sustainability Accounting Standards Board (SASB) framework and follow its guidelines to disclose critical measurements on the environment, society and governance of relevance to our business operations. Genmab regularly benchmarks and examines ESG activities, policies and disclosures to build a sustainable organization.
Genmab is committed to lawful and ethical behavior in all aspects of its business and requires all employees and the Board of Directors to comply with applicable laws and regulations.
Genmab is committed to transparency of clinical trial research. We recognize the scientific and ethical value of sharing clinical trial information in a non-biased and timely manner to benefit diverse audiences. Transparency in clinical trials helps patients and health-care providers to make well-informed decisions about patients’ health. Rooted in science and inspired by patients, we are committed to our vision to fundamentally transforming the lives of people with cancer and other serious diseases.
Genmab has adopted a Code of Conduct (the “Code”) to promote ethical and compliant conduct in all aspects of our business. The Code is applicable to Genmab’s Board of Directors, Executive Management, employees and contingent workers globally. Aptly titled Code of Conduct – Our Values in Action, the Code seeks to engage and inspire our people to consider how their everyday activities should be conducted in a manner reflecting our core values of innovation, determination, integrity, and teamwork. The Code reflects the standards of conduct we expect from our own people as well as our partners, vendors, suppliers and other third parties with whom we engage. All employees and contractors are required to complete annual training on the Code with their commitment to adhere to it. The Code was most recently amended by the Board of Directors in June 2023.
Genmab has a strong culture of quality with dedicated senior management leadership and commitment of employees at all levels to achieve and maintain a quality minded approach to everything we do.
Genmab is committed to building a sustainable and socially responsible biotech, one whose actions reliably benefits patients, stakeholders, and society as a whole. We are dedicated to further building a sustainable organization that meets those environmental, social and governance (ESG) criteria most relevant to our business, thereby creating long-term value for all of our stakeholders. At Genmab, we define Corporate Social Responsibility as the way in which we incorporate our purpose, values and vision with our business operations, interactions with stakeholders and our commitment to ESG issues. This Policy applies to activities undertaken by or on behalf of Genmab. Employees will adopt the CSR considerations described in this Policy into their day-to-day work activities.
The use of Data, both personal and non-personal, is essential to fulfilling Genmab’s core purpose; and Genmab is committed to handling Data with integrity and in an ethical and compliant manner considering the impact our actions may have on individuals and society.
At Genmab prioritizing diversity, equity, and inclusion means creating richer solutions, obtaining better results, and maximizing productivity, innovation, and creativity. Diversity allows for a variety of perspectives, and inclusion takes different ideas and perspectives into account, while equity ensures fair opportunities to succeed.
At Genmab, we seek to establish relationships with business partners, suppliers, vendors, and other third parties (collectively referred to as “Suppliers”) that provide the best overall quality and value and that demonstrate our shared commitment to ethical and responsible business practices. Consequently, for its Suppliers, Genmab has established certain standards that include ethical business practices and regulatory compliance. Genmab expects that its Suppliers will embrace the commitments included in this Supplier Code of Conduct.
Read Our Global Supplier Code of Conduct Policy: English / Japanese.
As a global biotechnology company committed to social responsibility and sustainability, Genmab strives to comply with all laws, regulations, and standards applicable to the conduct of its business. While governments have a duty to protect the human rights of their citizens, we recognize that businesses also have a critical role to play. Genmab is dedicated to conducting business in a way that respects the dignity of all people.
The objective of this policy is to ensure that all business activities of Genmab A/S including its subsidiaries and associated companies comply with international economic or financial sanctions and international export controls.
Enabling employees and external stakeholders to speak up when they observe potential misconduct or have concerns about matters relating to our business is vital to retaining our strong Genmab culture and to doing the right thing. The Genmab Speak Up Policy allows for confidential and (where allowed) anonymous reports that will be directed to Genmab Compliance for initial triage and handling. This approach renders the reporting process more accessible and easier to navigate.
Importantly, our new policy also extends protections not only to our regular employees, but also contingent staff, part-timers, temp staff, trainees, interns (both current and former) and others who choose to report their concerns.
Speak Up Compliance Hotline
• 24/7 – Online or by Phone
• GenmabSpeakUp.ethicspoint.com
• Denmark: 80-83-01-69
• Netherlands: 0800-020-1556
• United States: 1-844-942-3289
• Japan: 0800-123-0136
The Board of Directors and Genmab’s Executive Management are committed to an integrated Corporate Social Responsibility (CSR) strategy, focusing on employee well-being, ethics and compliance in relation to our research, the environment and business ethics and transparency. Our tax policy is fully aligned with our business-driven CSR strategy: it reflects our commitment to business ethics and to building a sustainable organization, while the publication of our tax policy displays our focus on transparency.